StockData
Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc. (COGT) stock

COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$27.81−0.04 (-0.14%)

Close on Nov 18, 2026Market cap $4.83BP/E –Yield –

Cogent Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Cogent Biosciences's total debt was $44.25M at Sep 30, 2025. For fiscal 2024 it was $0.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$44.25M–
Q2 FY2025Jun 30, 2025$43.95M–
Q4 FY2024Dec 31, 2024$0–

More Cogent Biosciences figures

See a number that looks wrong?